TELIGENE
Teligene was established in 2011. It is a high-tech pharmaceutical research and development company focusing on the research and development and industrialization of small molecule innovative drugs. The company's senior technical management team is experienced and familiar with cutting-edge drug development technologies and development trends at home and abroad. The company mainly aims to research and develop hot spots and develop trends of new international small molecule targeted anti-tumor drugs, and designs, screens, optimizes and develops original small molecule targeted anti-tumor drugs with independent intellectual property rights.
TELIGENE
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Nanjing, Jiangsu, China
Country:
China
Website Url:
http://www.teligene.com
Status:
Active
Total Funding:
92.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Azure DNS GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region
Similar Organizations
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Investors List
ShenZhen GTJA Investment Group
ShenZhen GTJA Investment Group investment in Series C - Teligene
Shenzhen Capital Group
Shenzhen Capital Group investment in Series B - Teligene
ShenZhen GTJA Investment Group
ShenZhen GTJA Investment Group investment in Series B - Teligene
IDG Capital
IDG Capital investment in Series B - Teligene
CCB Capital
CCB Capital investment in Series B - Teligene
Loyal Valley Capital
Loyal Valley Capital investment in Series B - Teligene
Official Site Inspections
http://www.teligene.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Teligene"
Teligene - Crunchbase Company Profile & Funding
Teligene was established in 2011. It is a high-tech pharmaceutical research and development company focusing on the research and development and industrialization of small molecule …See details»
Teligent Canada - Work hard, and be nice to people.
This has defined who we are both as individuals and as an organization. At Teligent, we have a bold vision to deliver, with care. Learn more about: Who We Are. Discover opportunities to …See details»
Our Canadian Team - Teligent Canada
Building from our roots in Buena Vista, New Jersey, we are transforming ourselves into a high-performance, R&D-centered organization. Our aspiration is to be a leading member of the …See details»
Who We Are - Teligent
Our Management Team - Teligent
Our Executive Management Team is committed to delivering our bold vision. Building from our roots in Buena Vista, New Jersey, we are transforming ourselves into...See details»
Teligene Company Profile 2024: Valuation, Funding & Investors
Teligene General Information Description. Developer and researcher of small-molecule drugs intended to improve cancer patient outcomes. The company is dedicated to develop innovative …See details»
Teligene - Funding, Financials, Valuation & Investors - Crunchbase
Teligene is a drug discovery company edicating to developing innovative small-molecule drugs.See details»
Careers - Teligent Canada
Mar 21, 2018 There are three pillars that shape the kind of company that we are building. First, we are driven by robust scientific and technical rigor. We are a science-driven organization. …See details»
Teligene - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Teligene is a drug discovery company edicating to developing innovative small-molecule drugs.See details»
Teligent Company Profile - Office Locations, Competitors ... - Craft
Nov 10, 2021 Teligent has 4 employees across 4 locations and $45.31 m in annual revenue in FY 2020. See insights on Teligent including office locations, competitors, revenue, financials, …See details»
Jason Grenfell-Gardner - Teligent Canada
Mar 21, 2018 Jason is the President and Chief Executive Officer of Teligent, Inc., where he is leading our transformation into an R&D-centered pharmaceutical company. Prior to joining …See details»
Teligene - Contacts, Employees, Board Members, Advisors & Alumni
Teligene is a drug discovery company edicating to developing innovative small-molecule drugs.See details»
Generic drugmaker Teligent files for Chapter 11, plans sale
Oct 14, 2021 Publicly traded Teligent filed for Chapter 11 protection, opens new tab in U.S. bankruptcy court in Wilmington, Delaware, with nearly $130 million in debt, saying the COVID …See details»
Careers - Teligent
Dec 7, 2021 There are three pillars that shape the kind of company that we are building. First, we are driven by robust scientific and technical rigor. We are a science-driven organization. …See details»
Our Science - Teligent Canada
Our commitment to robust science begins in our R&D lab, where we use the latest equipment and technologies to develop and formulate a medicine.See details»
Microsoft Teams from TeligentIP - TeligentIP
Transform your organization’s communication and productivity. Teligent helps you add phone services to your Microsoft Teams deployment to transform it into a fully featured UC …See details»
What Our People Say - Teligent
The Teligent spark empowers us to dream of a brighter future. To envision our work having a deeper impact on others’ lives. To build something that is bigger than ourselves. Our journey is …See details»
Home | Telligen
Nov 22, 2024 Telligen is a trusted partner for U.S. government health agencies, state Medicaid agencies, self-funded employer and Taft-Hartley health plans, and managed care …See details»
Products - Teligent Canada
At Teligent, we are committed to consistent supply that is developed and manufactured exclusively for Canada. For medical information and adverse event reporting on our products …See details»